Ondine presents nasal infection prevention data at UK conference
Ondine Biomedical presented clinical data on its Steriwave nasal photodisinfection technology at the Infection Prevention and Control Conference in Birmingham, highlighting its potential to reduce healthcare-associated infections. The presentation by Dr. Nicolas Loebel emphasized the clinical and economic benefits of nasal decolonization strategies using light-activated antimicrobial therapy. Data from use in Canada and the UK showed reduced surgical site infections and ICU-acquired pneumonia, leading to shorter hospital stays and improved patient flow.
- ▪Ondine Biomedical presented Steriwave nasal photodisinfection data at a UK infection prevention conference attended by NHS decision-makers.
- ▪Clinical data from Canada and the UK showed reductions in surgical site infections and ICU-acquired pneumonia with Steriwave use.
- ▪Steriwave is a single-dose, nurse-administered, light-activated therapy that eliminates nasal pathogens and is classified by NHS Supply Chain as an Innovation Product.
- ▪Health economic analysis presented indicated that healthcare-associated infections add an average of 9.7 hospital days per major surgical site infection.
- ▪CEO Carolyn Cross noted growing UK interest in non-antibiotic infection prevention approaches, reflecting broader engagement with NHS institutions.
- ▪The conference covered infection control strategies, antimicrobial stewardship, and operational challenges within the NHS.
Opening excerpt (first ~120 words) tap to expand
BIRMINGHAM - Ondine Biomedical Inc. (LON:OBI) presented clinical data on its Steriwave nasal photodisinfection technology at the Infection Prevention and Control Conference held Monday and Tuesday at The National Conference Centre in Birmingham. Dr. Nicolas Loebel, the company’s President and Chief Technology Officer, delivered a presentation titled "Nasal Photodisinfection: Addressing the Hidden Costs of HAIs" to clinicians, infection prevention specialists, and NHS decision-makers, according to a press release statement. The presentation focused on healthcare-associated infections and nasal decolonization strategies. Ondine reported that data from Steriwave use in Canada and the UK showed reductions in surgical site infections and ICU-acquired pneumonia.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Investing.com — News.